Mass layoffs at the FDA, including senior negotiators, have disrupted the process of reauthorizing user fee programs that ...

Makary announced the change during his first interview as commissioner. He spent much of the conversation with Megyn Kelly ...

The firings of most of the negotiators and their project managers throw into disarray the complex process of reauthorizing ...

A Cambridge biotech has taken over development of a Roche rare disease drug, Cue Biopharma signed a deal with Boehringer ...

The pharmaceutical industry is on the brink of massive transformation driven by cutting-edge technology and strategic collaboration. Purdue University is on the forefront of Pharma 4.0 by partnering ...

Trump could use the findings of the probe to impose certain trade restrictions on pharma products, including tariffs.

With biotech firms caught in the crosshairs of Trump’s tariffs, the levy could prove to be a boon for domestic producers but ...

On The Readout LOUD podcast, STAT reporters talked with BIO's CEO John Crowley about RFK Jr. and tariffs, and discussed calls ...

The threat of tariffs has put the pharma industry through the wringer this week. On Wednesday, a week after instituting widespread tariffs and a day after promising that “major” tariffs were headed ...

In a jobs market marred by a hiring slowdown, Staffline (STAF) appears to be bucking the trend. Unlike its larger peers, the Aim-listed blue-collar recruiter grew revenue, underlying operating profits ...

BioMarin Pharmaceutical Inc.’s BMRN share price has dipped by 10.70%, which has investors questioning if this is right time to buy.

Pharmaceutical companies rely on a vast and intricate global ... Trade association Biotechnology Innovation Organization (BIO) released survey results and analysis last month, which highlighted ...